11/8/2022 6:32:40 AM
Perrigo Q3 Net Loss/shr From Cont. Ops. $0.39 Vs. Loss/shr $0.40 Last Year
11/3/2022 12:44:10 PM
Perrigo Company plc (PRGO) Declares Quarterly Dividend of $ 0.26, Record Date 12/2/2022
11/3/2022 12:15:17 PM
Perrigo Declares Quarterly Dividend Of $0.26/share, Payable Dec. 20/ Record Dec. 2
10/26/2022 8:33:25 AM
Perrigo Gets Notification Of Postponement For Joint FDA Committee To Review Opill Daily Oral Contraceptive For OTC Use
9/12/2022 9:39:47 AM
Perrigo :FDA Panel Scheduled Meeting On Nov 18 To Review Application For Opill Daily Oral Contraceptive For OTC Use
8/9/2022 6:32:19 AM
Perrigo Q2 Loss Per Share $0.48; Adj EPS $0.43
8/2/2022 9:25:04 AM
Perrigo Declares Quarterly Dividend Of $0.26/shr; Payable September 20/record September 2
8/2/2022 9:23:06 AM
Perrigo Company plc (PRGO) Declares Quarterly Dividend of $ 0.26, Record Date 9/2/2022
7/11/2022 6:02:17 AM
Perrigo's HRA Pharma Submits Application To FDA For OTC Birth Control Pill In The United States
5/11/2022 6:37:47 AM
Perrigo Company plc (PRGO) Has Raised Its FY22 EPS Estimate To 2.30 - 2.40 From 2.10 - 2.30